Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors (Q43442484)

23 November 2017

title

Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors (English)

1 reference

23 November 2017

1 reference

Aden Ka-Yin Chan

1

1 reference

23 November 2017

Jesse Chung-Sean Pang

2

1 reference

23 November 2017

Nellie Yuk-Fei Chung

3

1 reference

23 November 2017

Kay Ka-Wai Li

4

1 reference

23 November 2017

Wai Sang Poon

5

1 reference

23 November 2017

Danny Tat-Ming Chan

6

1 reference

23 November 2017

Zhifeng Shi

7

1 reference

23 November 2017

Liang Chen

8

1 reference

23 November 2017

Liangfu Zhou

9

1 reference

23 November 2017

Ho-Keung Ng

10

1 reference

23 November 2017

language of work or name

1 reference

13 September 2013

1 reference

23 November 2017

1 reference

23 November 2017

volume

27

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

332-342

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.165

23 November 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A method and server for predicting damaging missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Capicua regulates cell proliferation downstream of the receptor tyrosine kinase/ras signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

CIC, a member of a novel subfamily of the HMG-box superfamily, is transiently expressed in developing granule neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

FUSE-binding protein is developmentally regulated and is highly expressed in mouse and chicken embryonic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Oligodendrogliomas: new insights from the genetics and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2013.165

1 reference

Dimensions Publication ID

23 November 2017

1012176186

0 references

1 reference